Henry Schein Announces Two New Directors
With these changes, Henry Schein continues to have 15 directors, including 10 independent directors.
"We are extremely fortunate to attract such high-quality directors to our Board. Joseph brings to Henry Schein comprehensive knowledge of pharmaceuticals, management and sales, and Kurt has extensive experience in distribution logistics, as well as in corporate finance and accounting. We look forward to the contributions both will make to advance the strategic goals of the Company," said
Mr. Herring's career in health care spans more than 35 years. He served as CEO of the drug-development services company
Mr. Kuehn spent his entire career, which spanned nearly four decades, at
Mr. Matthews was named a director of Henry Schein in 2002, and has worked as an independent consultant and venture capitalist since 1989. From 1978 to 1988, Mr. Matthews served in various senior management positions for
Dr. Sullivan was named a director of Henry Schein in 2003. He is President Emeritus of
After retiring from the Company's Board of Directors, it is expected that Mr. Mathews and Dr. Sullivan will continue their relationship with Henry Schein. Mr. Matthews will provide consulting services to the Company on various matters, including marketing, strategy and executive education. Dr. Sullivan will assume the role of
"
About
The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 110,000 branded products and Henry Schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.
Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 33 countries. The Company's sales reached a record $10.6 billion in 2015, and have grown at a compound annual rate of approximately 15 percent since Henry Schein became a public company in 1995. For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein and @HenrySchein on Twitter.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/henry-schein-announces-two-new-directors-300277692.html
SOURCE
Investors, Steven Paladino, Executive Vice President and Chief Financial Officer, steven.paladino@henryschein.com, (631) 843-5500, or Carolynne Borders, Vice President, Investor Relations, carolynne.borders@henryschein.com, (631) 390-8105, or Media, Gerard Meuchner, Vice President, Chief Global Communications Officer, gerard.meuchner@henryschein.com, (631) 390-8227